ɔːlðˈoʊ klɪnˈɪʃənz æt saʊθˈæmptən fˈɛlt pɹˈoʊtɑːn bˈiːm θˈɛɹəpi wʊd nˌɑːt biː bˌɛnɪfˈɪʃəl ɪn ðɪs kˈeɪs, ɪt wʌz dɪskˈʌst wɪððə kˈɪŋz ænd ɹᵻfˈɜːd tə ðə pɹˈoʊtɑːn klˈɪnɪkəl ɹˈɛfɹəns pˈænəl ɔːlðˈoʊ mˌɛdəlˌɑːblɐstˈoʊmə ɪz nˌɑːt ɐn ɐpɹˈuːvd dˌaɪəɡnˈoʊsɪs tə kwˈɔlᵻfˌaɪ fɚðɪ ˌoʊvɚsˈiːz pɹˈoʊɡɹæm.
Although clinicians at Southampton felt proton beam therapy would not be beneficial in this case, it was discussed with the Kings and referred to the Proton Clinical Reference Panel although medulloblastoma is not an approved diagnosis to qualify for the overseas programme.